Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 24, 2025 03:00 ET | Source: Dipharma Francis S.r.l

Mario Biazzi, Founder of Dipharma Group, and His Contribution to the History of Nitroglycerin

MILAN, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active Pharmaceutical...
December 27, 2024 09:30 ET | Source: Bright Green Corporation

LYNN STOCKWELL ENTERS INTO A RESTRUCTURING SECURITY AGREEMENT (“RSA”) WITH BRIGHT GREEN CORPORATION AND ASSUMES THE ROLE OF EXECUTIVE CHAIR AND CEO.

GRANTS, NEW MEXICO, Dec. 27, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC: BGXX) (“Bright Green” or the “Company”) announced today that Lynn Stockwell has agreed to terms for a...
October 26, 2023 03:59 ET | Source: Dipharma Francis S.r.l

Dipharma Receives the 2nd GMP Certification from Brazilian ANVISA

MILAN, Italy, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...
February 10, 2023 10:29 ET | Source: Dipharma Francis S.r.l

Dipharma completes second phase of CGMP expansion at its Kalamazoo site

MILAN, Italy, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a global CDMO and leading manufacturer of Active Pharmaceutical Ingredients and advanced Intermediates, announced...
December 01, 2022 08:46 ET | Source: Dipharma Francis S.R.L

Dipharma receives GMP certification from Brazilian ANVISA

MILAN, Italy, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a leading Contract Development and Manufacturing Organization (CDMO) and a global manufacturer of Active...
October 14, 2020 10:14 ET | Source: Global Market Estimates

India Active Pharmaceutical Ingredient [API] Industry Report

BROOKLYN, New York, Oct. 14, 2020 (GLOBE NEWSWIRE) -- According to Global Market Estimates, the Indian API Market will grow rapidly at a CAGR of 8.57% during the 2020-2026 phase. The Indian drug...